...
首页> 外文期刊>Neuro-Oncology >Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults
【24h】

Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults

机译:成像增长作为IDH-突变体和1P / 19Q-CODELTED OLIGODENDROGLIOMA在成人中的恶性和侵袭性等级的预测因子

获取原文
获取原文并翻译 | 示例

摘要

Background. We quantified the spontaneous imaging growth rate of oligodendrogliomas. We assessed whether (i) it discriminates between World Health Organization (WHO) grade II and grade III oligodendrogliomas, and (ii) grade III oligodendrogliomas with neo-angiogenesis are associated with more fast growth rates (= 8 mm/y).Methods. This work employed a retrospective bicentric cohort study (2010-2016) of adult patients harboring a newly diagnosed supratentorial oligodendroglioma, isocitrate dehydrogenase (/DH) mutant and 1p/19q codeleted (WHO 2016 classification), with a minimum of 2 available MRIs before any treatment (minimum 6-week interval) to measure the spontaneous tumor growth rate.Results. We included 108 patients (age 44.7 +/- 14.1 y, 60 males). The tumor growth rate was higher in grade Ill oligodendrogliomas with neo-angiogenesis (n = 37, median 10.4 mm/y, mean 10.0 +/- 6.9) than in grade Ill oligodendrogliomas with increased mitosis count only (cutoff = 6 mitoses, n = 18, median 3.9 mm/y, mean 4.5 +/- 3.2; P= 0.004), and higher than in grade II oligodendrogliomas (n = 53, median 2.3 mm/y, mean 2.8 +/- 2.2; P 0.001). There was increased prevalence of fast tumor growth rates in grade Ill oligodendrogliomas with neo-angiogenesis (54.1%) compared with grade Ill oligodendrogliomas with increased mitosis count only (11.1%; P 0.001), and in grade II oligodendrogliomas (0.0%; P 0.001). The tumor growth rate trends did not differ between centers (P= 0.121). Neo-angiogenesis (P 0.001) and mitosis count at = 9 (P= 0.013) were independently associated with tumor growth rates = 8 mm/year. A tumor growth rate _a mm/year was the only predictor independently associated with shorter progression-free survival (P= 0.041).Conclusions. The spontaneous tumor growth rate recapitulates oligodendroglioma aggressiveness, permits identification of grade III oligodendrogliomas preoperatively when = 8 mm/year, and questions the grading by mitosis count.
机译:背景。我们量化了少突的自发性成像生长速率。我们评估了(i)II之间判断世界卫生组织(世卫组织)II级和III级oligodendrogliomas,以及(II)具有新血管生成的III级寡替替替孕术与更快速的生长速率(> = 8mm / y)相关。方法。这项工作雇用了一项回顾性的双关节队(2010-2016)的成人患者,涉及新诊断的Supratential Oligodendroglioma,异柠檬酸脱氢酶(/ DH)突变体和1P / 19Q Codeleted(Who 2016分类),其中至少有2个可用的MRIS治疗(至少6周间隔)测量自发性肿瘤生长率。结果。我们包括108名患者(44.7岁+/- 14.1 y,60岁)。肿瘤生长速率较高,具有新血管生成(n = 37,中位数10.4mm / y,平均10.0 +/-6.9),而不是在等级的少芽孢杆菌中,仅增加有丝分裂计数(截止值> = 6条点球,n = 18,中学3.9 mm / y,平均值4.5 +/- 3.2; p = 0.004),高于II级少突(n = 53,中位数2.3mm / y,平均2.8 +/- 2.2; p <0.001) 。与新血管生成(54.1%)相比,与新血管生成(54.1%)的快速肿瘤生长速率普及增加(54.1%),其含量增加了有丝分裂数量(11.1%; p <0.001),少于少突(0.0%; p <0.001)。肿瘤生长速率趋势在中心之间没有差异(P = 0.121)。新血管生成(p <0.001)和拟分荧光病计数在> = 9(p = 0.013)与肿瘤生长率> = 8mm /岁/次单独相关。肿瘤生长速率_a mm /年是唯一与无进展存活(p = 0.041)的唯一相关的预测因子.Conclusions。自发性肿瘤生长速率促进了寡突肌瘤侵袭性,允许术前鉴定III级少曲调术术后> = 8毫米/年,并通过有丝分裂计数进行分级。

著录项

  • 来源
    《Neuro-Oncology 》 |2020年第7期| 993-1005| 共13页
  • 作者单位

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuropathol Paris France;

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

    Univ Calif Los Angeles Dept Neurosurg Los Angeles CA USA;

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuroradiol Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuropathol Paris France;

    Hop La Pitie Salpetriere Dept Neuroradiol Paris France;

    Hop La Pitie Salpetriere Dept Neuro Oncol Paris France;

    Hop La Pitie Salpetriere Dept Neuro Oncol Paris France;

    Hop La Pitie Salpetriere Dept Neuroradiol Paris France;

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuropathol Paris France|Pasteur Inst Lab Expt Neuropathol Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuroradiol Paris France;

    Hop La Pitie Salpetriere Dept Neuro Oncol Paris France;

    Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France|GHU St Anne Hosp Dept Neuropathol Paris France;

    Hop La Pitie Salpetriere Dept Neurosurg Paris France;

    Gustave Roussy Univ Hosp Dept Radiotherapy Villejuif France;

    Univ Hosp Grp Psychiat & Neurosci GHU St Anne Hosp Dept Neurosurg Paris France|Paris Descartes Univ Sorbonne Paris Cite Paris France|Inst Psychiat & Neurosci Paris INSERM Unit 1266 Imaging Biomarkers Brain Disorders IMA BRAIN Paris France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    oligodendroglioma; IDH-mutant; 1p/19q codeletion; imaging growth rate; velocity index;

    机译:oligodendroglioma;IDH突变体;1P / 19Q Comepletion;成像增长率;速度指数;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号